Neural Network Modeling of Voluntary Single-Joint Movement Organization II. Parkinson’s Disease
暂无分享,去创建一个
[1] A. W. Wiegner,et al. Role of agonist and antagonist muscles in fast arm movements in man , 2004, Experimental Brain Research.
[2] D. Geschwind,et al. Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey , 1989, Neuroscience.
[3] O. Hornykiewicz,et al. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 1990, Neurochemistry International.
[4] S. Gentleman,et al. Spinal cord dopaminergic neurons: Evidence for an uncrossed nigrospinal pathway , 1979, Neuropharmacology.
[5] G. Stelmach,et al. Force production characteristics in Parkinson's disease , 1989, Experimental Brain Research.
[6] C. Ghez,et al. Trajectory control in targeted force impulses , 1987, Experimental Brain Research.
[7] R. Tanaka,et al. Disorder in reciprocal innervation upon initiation of voluntary movement in patients with Parkinson's disease , 2004, Experimental Brain Research.
[8] C. Marsden,et al. Performance of simultaneous movements in patients with Parkinson's disease. , 1986, Brain : a journal of neurology.
[9] J. Cooke,et al. Movement-related phasic muscle activation. II. Generation and functional role of the triphasic pattern. , 1990, Journal of neurophysiology.
[10] J C Rothwell,et al. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[11] G. Stelmach,et al. Movement accuracy constraints in Parkinson’s disease patients , 2000, Neuropsychologia.
[12] G. Stelmach,et al. Interlimb coordination in Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.
[13] A. Benazzouz,et al. MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies , 2004, Experimental Brain Research.
[14] Howard N. Zelaznik,et al. Advances in Motor Learning and Control , 1996 .
[15] A. Carlsson,et al. 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.
[16] A. Björklund,et al. Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing , 1979, Brain Research.
[17] Stavros J. Perantonis,et al. A neural network model of Parkinson's disease bradykinesia , 2006, Neural Networks.
[18] K. Flowers. Visual "closed-loop" and "open-loop" characteristics of voluntary movement in patients with Parkinsonism and intention tremor. , 1976, Brain : a journal of neurology.
[19] Vassilis Cutsuridis,et al. Neural Model of Dopaminergic Control of Arm Movements in Parkinson's Disease Bradykinesia , 2006, ICANN.
[20] M L Latash,et al. Organizing principles for single joint movements: V. Agonist-antagonist interactions. , 1992, Journal of neurophysiology.
[21] C. Ghez,et al. Trajectory control in targeted force impulses , 1987, Experimental Brain Research.
[22] T. Ebner,et al. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced hemiparkinsonism on the kinematics of a two-dimensional, multijoint arm movement in the rhesus monkey , 1992, Neuroscience.
[23] J. Weil-Fugazza,et al. Dorsal and ventral dopaminergic innervation of the spinal cord: Functional implications , 1993, Brain Research Bulletin.
[24] C Ghez,et al. Trajectory control in targeted force impulses , 2004, Experimental Brain Research.
[25] J. Chalmers,et al. Direct projection of catecholamine (presumably dopamine)-containing neurons from hypothalamus to spinal cord , 1979, Neuroscience Letters.
[26] R. Roth,et al. MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primate , 1990, Neuroscience Letters.
[27] Gibberd Fb. The management of Parkinson's disease. , 1986 .
[28] J. Morrison,et al. Brainstem dopaminergic neurons project to monkey parietal cortex , 1988, Neuroscience Letters.
[29] J. Seal,et al. Neuronal Activity in Area 4 and Movement Parameters Recorded in Trained Monkeys After Unilateral Lesion of the Substantia Nigra , 1983 .
[30] B. Berger,et al. Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease , 1991, Annals of neurology.
[31] M. Yoshida,et al. A new dopaminergic terminal plexus in the ventral horn of the rat spinal cord. Immunohistochemical studies at the light and electron microscopic levels , 1990, Experientia.
[32] L. Tremblay,et al. Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism , 1989, Brain Research.
[33] J. Kaas,et al. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys , 1992, The Journal of comparative neurology.
[34] G. Stelmach,et al. Parkinsonian arm movements as altered by task difficulty. , 1996, Parkinsonism & related disorders.
[35] J. Cooke,et al. Movement-related phasic muscle activation. I. Relations with temporal profile of movement. , 1990, Journal of neurophysiology.
[36] B. Berger,et al. Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: A radioautographic study , 1988, The Journal of comparative neurology.
[37] J Jacquy,et al. Parkinsonian bradykinesia is due to depression in the rate of rise of muscle activity , 1992, Annals of neurology.
[38] M. Hallett,et al. A physiological mechanism of bradykinesia. , 1980, Brain : a journal of neurology.
[39] M. Hallett,et al. Ballistic flexion movements of the human thumb. , 1979, The Journal of physiology.
[40] B. Bioulac,et al. Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons , 2004, Experimental Brain Research.
[41] B. Bioulac,et al. MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study , 1985, Brain Research.
[42] R. Watts,et al. The role of motor cortex in the pathophysiology of voluntary movement deficits associated with parkinsonism. , 1992, Neurologic clinics.
[43] Vassilis Cutsuridis,et al. Does Abnormal spinal Reciprocal Inhibition lead to Co-Contraction of Antagonist Motor Units? A Modeling Study , 2007, Int. J. Neural Syst..
[44] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[45] Sanford P. Markey,et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.
[46] J. Cooke,et al. Initial agonist burst duration depends on movement amplitude , 2004, Experimental Brain Research.
[47] D. Jacobowitz,et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[48] P S Goldman-Rakic,et al. Widespread origin of the primate mesofrontal dopamine system. , 1998, Cerebral cortex.
[49] M. Hallett,et al. EMG analysis of stereotyped voluntary movements in man. , 1975, Journal of neurology, neurosurgery, and psychiatry.
[50] J. Abbs,et al. Task-dependent variations in parkinsonian motor impairments. , 1991, Brain : a journal of neurology.
[51] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.